5-Amino-1MQ Capsules
Aug 24th 2026
5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase, or NNMT, rather than a peptide. The product contains the non-iodide 5-amino-1-methylquinolinium form identified in the specifications below.
For research use only. Not for human or animal use.
5-Amino-1MQ identity and NNMT research context
Nicotinamide N-methyltransferase, commonly abbreviated NNMT, is a cytosolic enzyme that transfers a methyl group from S-adenosylmethionine to nicotinamide. The reaction produces 1-methylnicotinamide and S-adenosylhomocysteine, linking NNMT research to cellular methyl-donor balance and nicotinamide metabolism.
5-Amino-1MQ has been studied as an experimental NNMT inhibitor in cell-based systems and high-fat-diet mouse models. Published work has measured NNMT-linked metabolites, tissue composition, and related biochemical endpoints under those specific conditions. Those findings remain specific to the reported models, and results from other NNMT inhibitors should not be attributed to 5-Amino-1MQ.
Accordingly, 5-Amino-1MQ is described as a chemical probe for NNMT and methylquinolinium research rather than as a source of direct weight, metabolic, disease, or personal outcomes.
Capsule specifications and chemical identity
The current product record identifies 60 capsules with 50 mg of labeled 5-Amino-1MQ per capsule. These values describe the supplied package and are not a research protocol or recommendation.
The current material is identified by the following specifications:
- Chemical name: 5-amino-1-methylquinolinium
- Classification: small-molecule NNMT inhibitor
- Molecular formula: C10H11N2+
- Molecular weight: 159.21 g/mol
- CAS number: 685079-15-6
- PubChem CID: 950107
- Presentation: 60 capsules, 50 mg per capsule in the current product package
- Minimum purity specification for the underlying material: at least 98.5%
Capsule products receive purity testing under the current testing program, and the most recent applicable COA provides the batch-specific analytical result.
The positive charge in C10H11N2+ reflects the quinolinium cation identified for this material.
Capsule and powder relationship
5-Amino-1MQ Capsules and 5-Amino-1MQ Powder are separate product records for different supplied formats. Neither format changes the compound’s classification as a small molecule. The powder record provides powder-specific package details, while the capsule record provides the capsule count and labeled amount. Available COAs are public and may follow the underlying tested material rather than requiring a separate report for every finished format. Researchers comparing 5-Amino-1MQ for sale as a laboratory material can review the non-iodide chemical identity, capsule specifications, and public analytical documentation before requesting access to professional pricing. Professional pricing requires an approved account and login.
Related catalog pathways include Mitochondrial Research and Metabolic Research, where materials are grouped by experimental context rather than compound class.
Frequently asked questions
Is 5-Amino-1MQ a peptide?
No. It is a methylquinolinium small molecule studied as an NNMT inhibitor. It does not have an amino-acid peptide sequence.
What is the molecular identity of 5-Amino-1MQ?
The product contains 5-amino-1-methylquinolinium with the molecular formula C10H11N2+, CAS number 685079-15-6, molecular weight 159.21 g/mol, and PubChem CID 950107.
What has 5-Amino-1MQ been studied in?
Published work includes cell-based research and high-fat-diet mouse models examining NNMT-linked biochemical and tissue endpoints. Those findings remain preclinical and specific to the reported experimental conditions.
How do the capsule and powder pages differ?
Both records concern 5-Amino-1MQ, but each provides specifications for a different supplied format. The capsule record lists 60 capsules at 50 mg each, while the powder record provides its separate package details.
View Product Specifications
Review Available Documentation